These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 29390581
1. Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report. Grushchak S, Joy C, Gray A, Opel D, Speiser J, Reserva J, Tung R, Smith SE. Medicine (Baltimore); 2017 Dec; 96(51):e9452. PubMed ID: 29390581 [Abstract] [Full Text] [Related]
2. Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms. Suzuki Y, Kato S, Kohno K, Satou A, Eladl AE, Asano N, Kono M, Kato Y, Taniwaki M, Akiyama M, Nakamura S. Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410 [Abstract] [Full Text] [Related]
7. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review. Samhouri Y, Ursu S, Dutton N, Tanvi V, Fazal S. J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479 [Abstract] [Full Text] [Related]
8. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases]. Nong L, Wang W, Liang L, Li D, Li X, Li T. Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr 18; 55(2):308-314. PubMed ID: 37042142 [Abstract] [Full Text] [Related]
9. Blastic Plasmacytoid Dendritic Cell Neoplasm. Jain A, Sweet K. J Natl Compr Canc Netw; 2023 May 18; 21(5):515-521. PubMed ID: 37156483 [Abstract] [Full Text] [Related]
11. IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression. Tang H, Panse G, Braddock D, Perincheri S, Xu ML, McNiff JM. J Cutan Pathol; 2023 Jul 18; 50(7):595-600. PubMed ID: 37082914 [Abstract] [Full Text] [Related]
12. [Clinical Characteristics of CD4-CD56+ Blastic Plasmacytoid Dendritic Cell Neoplasm]. He HS, Wei YF, Ji XY, Xu YH, Yang YQ, Jin XK. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr 18; 32(2):588-594. PubMed ID: 38660871 [Abstract] [Full Text] [Related]
13. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches. Cheng W, Yu TT, Tang AP, He Young K, Yu L. Curr Med Sci; 2021 Jun 18; 41(3):405-419. PubMed ID: 34218354 [Abstract] [Full Text] [Related]
14. Cutaneous presentation preceding acute myeloid leukemia with CD4+/CD56+ expression misdiagnosed as a blastic plasmocytoid dendritic cell neoplasm: A case report. Szablewski V, Costes V, Bret C, Dereure O, Yosr H, Alame M, Cacheux V. J Cutan Pathol; 2018 Aug 18; 45(8):610-614. PubMed ID: 29660158 [Abstract] [Full Text] [Related]
16. Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: a case report and review of the literature. Sugimoto KJ, Shimada A, Yamaguchi N, Imai H, Wakabayashi M, Sekiguchi Y, Izumi H, Ota Y, Komatsu N, Noguchi M. Int J Clin Exp Pathol; 2013 Aug 18; 6(11):2603-8. PubMed ID: 24228127 [Abstract] [Full Text] [Related]